Study of NIS793 and Other Novel Investigational Combinations With SOC Anti-cancer Therapy for the 2L Treatment of mCRC
Clinical trial NCT04952753 · TERMINATED
Trial details
- NCT number
- NCT04952753
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-15
- Primary completion
- 2025-01-20
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.